Close

News

Health ministry turns down SLAs’ demand for amending D&C Rules to define role of SLAs in monitoring clinical trials

3rd February 2014, India - The Union health ministry of India has turned down some of the state drug controllers' demand for an amendment in Rule 122DAC of the Drugs  & Cosmetics Act to further define the role of...

Cancer Aid Society urges govt to relax norms on oral morphine to provide relief to cancer patients

The Cancer Aid Society of India has urged the government to relax norms with respect to availability and accessibility of oral morphine in the country as thousands of cancer patients are enduring immense pain due to non availability of...

Roche NimbleGen Introduces Novel NGS Target Enrichment Solution for Methylation Assessment

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced the launch of the SeqCap Epi Target Enrichment System for DNA methylation assessment at single-base resolution. This system includes both a fixed content epigenome-wide design and a full range of custom target...

AMSilk Advances Silicone Breast Implant Coating

New research paper about the coating of silicone implants with recombinant spider silk. AMSilk has completed preclinical testing of its proprietary silicone implant coating made from spider silk. AMSilk's coating consists of a thin layer of spider silk proteins...

PharmaCell to Purchase Cell Therapy Production Facility from TiGenix

PharmaCell B.V. a leading Contract Manufacturing Organization for Cellular Therapies and Regenerative Medicine in Europe, announced today that it has entered into an agreement with TiGenix N.V. to purchase its state-of-the-art cell therapy production facility at the Chemelot site...

Breakthrough announced in treatment of patient with rare type of leukemia

A team of scientists from the University of Leicester has demonstrated a novel treatment for Hairy Cell Leukaemia (HCL), a rare type of blood cancer, using a drug administered to combat skin cancer. The research,...

Clever chemistry and a new class of antibiotics

As concerns about bacterial resistance to antibiotics grow, researchers are racing to find new kinds of drugs to replace ones that are no longer effective. One promising new class of molecules called acyldepsipeptides - ADEPs - kills bacteria in...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »